The Respiratory Viral Season Planning Window is Already Closing

I’m based in Texas, and most of our students are already back in school, or will start in the next week. Texas law nominally sets the earliest start date at the fourth Monday in August, which is August 24 this year. District of Innovation status has made that date mostly theoretical, and most districts now open about two weeks ahead of it.

Perhaps unexpectedly, that little bit of education law matters to infection prevention more than it looks like it should.

‍ ‍

Why does school return matter to a hospital?

‍School return is the an early signal we get that respiratory viral infection season is about to be underway. The infections often hit classrooms first, then households, then everywhere households go.

Healthcare doesn't feel it right away. That interval, between community transmission climbing and your census reflecting it, is the planning window. It's also the time that can tend to be spent on something else. By the time the patient volume spikes, you're deciding things in a hurry, and hurried decisions have a way of becoming policy nobody revisits.

‍ ‍

What should be decided now rather than in November?

‍Not the clinical protocols - those mostly exist and they’re probably solid (though worth a review). What's usually missing is who will decide what changes needs to happen and when those decisions are made.‍ ‍

Start with visitor policy. Ask three people at your facility who has authority to restrict visitation, and see whether you get the same answer. In a lot of organizations the honest answer is that decision and the authority is set during the week the decision is needed.

Write down what triggers a change. Community positivity rates, your own admissions or bed capacity, staff sick call-outs, a regional signal. Pick something specific and put a number on it. A threshold defined during a surge gets argued about, but a threshold agreed upon in August gets applied when it’s needed.

Do the cohorting math on paper now. Don’t just look at bed counts. Look at where you have private rooms, negative pressure availability, and which units could absorb a cohort without giving something critical up somewhere else.

Think ahead on employee health impacts. What would 10-15% staff absenteeism actually do to your schedule? When do you plan to launch your vaccination campaign? If you’re waiting until late fall to have these discucssions, you’ll already be behind the curve you're trying to get in front of.

‍ ‍

What signals should you be watching?

Pick two or three indicators now and start looking at them weekly, before they matter. It could be local health department respiratory surveillance, your own ED visit mix, staff call-outs. The specific data isn't really the point here, there are a number of data points that can be helpful, and what you choose will vary based on your patient population and what data you have access to. But you'll only recognize a change from baseline if you've been watching the baseline for a while, and a number you only start tracking in October doesn't tell you much in November.

‍ ‍

One thing worth doing this month

Block off an hour and write down four or five possible decisions your facility will face if respiratory volume climbs sharply — visitor restrictions, masking, cohorting, elective scheduling, staffing escalation. ‍Then add three columns for who makes the final decision, what would trigger it, and who needs to be inovlved or informed.

You may not be able to fill in all three columns for all five rows right now. But the exercise of putting together that grid is worth more than any protocol revision you'd manage in the same hour, and now you have gaps identified that you need to close earlier rather than later.

‍ ‍

If your respiratory season planning has been reactive, or your program is already stretched heading into fall, IP&MA works with facilities on surge planning, isolation and cohorting capacity, and the escalation structures that make these decisions faster when they're needed.

Next
Next

"We've Never Disagreed" Is Not Evidence of Agreement (Why We Test Our Own Infection Preventionists Annually)